Leukemia, Prolymphocytic - 55 Studies Found Completed : Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma : Leukemia Lymphoma : 2000-09-11 : Drug: fludarabine phosphate 30 Recruiting : Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL : Contiguous Stage II Small Lymphocytic Lymphoma Noncontiguous Stage II Small Lymphocytic Lymp : 2013-12-03 : Biological: MOR00208 Given by Active, not recruiting : Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia : Post-transplant Lymphoproliferative Disorder B-Cell Prolymphocytic Leu : 2014-05-30 : Drug: cyclophosphamide Given I Completed : A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) : Solid Tumors Chronic Lymphocytic Leukemia T-cell- : 2008-09-05 : Drug: MK-4827 MK-4827 in 10 mg and 100 mg capsules given daily in a 21 day dosing cycle (dose escalation Terminated : Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant : Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma : 2011-08-15 : Drug: lenalidomide Given PO Terminated : Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia : B-cell Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Drug: alvespimycin hydrochloride Active, not recruiting : PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia : Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Drug: ibrutinib Patients recei Active, not recruiting : Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia : Post-transplant Lymphoproliferative Disorder B-Cell Prolymphocytic Leu : 2014-05-30 : Drug: cyclophosphamide Given I Active, not recruiting : Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia : Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Recur : 2012-01-16 : Drug: Dinaciclib Given IV Recruiting : Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma : B-Cell Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Le : 2013-06-24 : Drug: Ibrutinib Given PO <<< Previous | Next >>>